Molecular aspects of diagnostic nucleolar and nuclear envelope changes in prostate cancer

Journal of Cellular Biochemistry

Volumn 91, Issue 1, 2004, Pages 170-184

  Fischer, Andrew H ^a   Bardarov Jr , Svetoslav ^a   Jiang, Zhong ^a  

^a UMASS MEMORIAL MEDICAL CENTER   (United States)

Author keywords

Clonal evolution; Molecular cytopathology; Nuclear envelope; Nucleolus

Indexed keywords

GROWTH FACTOR; PROTEIN P27; PROTEIN P53; RETINOBLASTOMA PROTEIN;

CELL CYCLE PROGRESSION; CELL NUCLEUS MEMBRANE; GENE EXPRESSION; HUMAN; NUCLEOLUS; ONCOGENE C MYC; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATIC INTRAEPITHELIAL NEOPLASIA; REVIEW; CELL DIVISION; EVOLUTION; MALE; METABOLISM; PATHOLOGY; PHYSIOLOGY; PROSTATE TUMOR; RIBOSOME; ULTRASTRUCTURE;

CELL DIVISION; CELL NUCLEOLUS; EVOLUTION; HUMANS; MALE; NUCLEAR ENVELOPE; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROSTATIC NEOPLASMS; RIBOSOMES;

EID: 3242772325     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.10735     Document Type: Review

References (91)

1. Alcaraz A, Barranco MA, Corral JM, Ribal MJ, Carrio A, Mallofre C, Llopis J, Cetina A, Alvarez-Vijande R. 2001. High-grade prostate intraepithelial neoplasia shares cytogenetic alterations with invasive prostate cancer. Prostate 47:29-35.
2. Amon A. 1999. The spindle checkpoint. Curr Opin Genet Dev 9:69-75.
3. Basolo F, Pollina L, Fontanini G, Fiore L, Pacini F, Baldanzi A. 1997. Apoptosis and proliferation in thyroid carcinoma: Correlation with bcl-2 and p53 protein expression. Br J Cancer 75:537-541.
4. Belmont AS. 2001. Visualizing chromosome dynamics with GFP. Trends Cell Biol 11:250-257.
5. Bostwick DG, Brawer MK. 1987. Prostatic intra-epithelial neoplasia and early invasion in prostate cancer. Cancer 59:788-794.
6. Bostwick DG, Eble JN. 1997. "Urologic Surgical Pathology." St. Louis: Mosby.
7. Bostwick DG, Pacelli A, Lopez-Beltran A. 1997. Ultrastructure of prostatic intraepithelial neoplasia. Prostate 33:32-37.
8. Broers JL, Raymond Y, Rot MK, Kuijpers H, Wagenaar SS, Ramaekers FC. 1993. Nuclear A-type lamins are differentially expressed in human lung cancer subtypes. Am J Pathol 143:211-220.
9. Broers JL, Machiels BM, Kuijpers HJ, Smedts F, van den Kieboom R, Raymond Y, Ramaekers FC. 1997. A- and B-type lamins are differentially expressed in normal human tissues. Histochem Cell Biol 107:505-517.
10. Cockell M, Gasser SM. 1999. Nuclear compartments and gene regulation. Curr Opin Genet Dev 9:199-205.
11. Crissman JD, Sakr WA, Hussein ME, Pontes JE. 1993. DNA quantitation of intraepithelial neoplasia and invasive carcinoma of the prostate. Prostate 22:155-162.
12. Dawson DM, Lawrence EG, MacLennan GT, Amini SB, Kung HJ, Robinson D, Resnick MI, Kursh ED, Pretlow TP, Pretlow TG. 1998. Altered expression of RET protooncogene product in prostatic intraepithelial neoplasia and prostate cancer. J Natl Cancer Inst 90:519-523.
13. De Marzo AM, Meeker AK, Epstein JI, Coffey DS. 1998a. Prostate stem cell compartments: Expression of the cell cycle inhibitor p27Kip1 in normal, hyperplastic, and neoplastic cells. Am J Pathol 153:911-919.
14. De Marzo AM, Nelson WG, Meeker AK, Coffey DS. 1998b. Stem cell features of benign and malignant prostate epithelial cells. J Urol 160:2381-2392.
15. Derenzini M, Trere D, Pession A, Govoni M, Sirri V, Chieco P. 2000. Nucleolar size indicates the rapidity of cell proliferation in cancer tissues. J Pathol 191:181-186.
16. Doll JA, Zhu X, Furman J, Kaleem Z, Torres C, Humphrey PA, Donis-Keller H. 1999. Genetic analysis of prostatic atypical adenomatous hyperplasia (adenosis). Am J Pathol 155:967-971.
17. Du YC, Stillman B. 2002. Yph1p, an ORC-interacting protein: Potential links between cell proliferation control, DNA replication, and ribosome biogenesis. Cell 109:835-848.
18. Epstein JI, Berry SJ, Eggleston JC. 1984. Nuclear roundness factor. A predictor of progression in untreated stage A2 prostate cancer. Cancer 54:1666-1671.
19. Ettler HC, Joseph MG, Downing PA, Suskin NG, Wright VC. 1999. Atypical squamous cells of undetermined significance: A cytohistological study in a colposcopy clinic. Diagn Cytopathol 21:211-216.
20. Fernandez PL, Hernandez L, Farre X, Campo E, Cardesa A. 2002. Alterations of cell cycle-regulatory genes in prostate cancer. Pathobiology 70:1-10.
21. Fischer AH, Bond JA, Taysavang P, Battles OE, Wynford-Thomas D. 1998a. Papillary thyroid carcinoma oncogene (RET/PTC) alters the nuclear envelope and chromatin structure. Am J Pathol 153:1443-1450.
22. Fischer AH, Chaddee DN, Wright JA, Gansler TS, Davie JR. 1998b. Ras-associated nuclear structural change appears functionally significant and independent of the mitotic signaling pathway. J Cell Biochem 70:130-140.
23. Fischer AH, Philips A, Taysavang P, McKenney JK, Amin MB. 2001a. Method for procuring specific populations of viable human prostate cells for research. Lab Invest 81:501-507.
24. Fischer AH, Taysavang P, Weber C, Wilson K. 2001b. Nuclear envelope organization in papillary thyroid carcinoma. Histol Histopathol 16:1-14.
25. Fischer AH, Taysavang P, Jhiang SM. 2003a. Nuclear envelope irregularity is induced by RET/PTC during interphase. Am J Pathol 163:1091-1100.
26. Fischer AH, Young KA, DeLellis RA. 2003b. Incorporating the criteria of malignancy into the evolutionary framework for cancer. Submitted for publication.
27. Fornaro M, Manes T, Languino LR. 2001. Integrins and prostate cancer metastases. Cancer Metastasis Rev 20:321-331.
28. Frank DJ, Edgar BA, Roth MB. 2002. The Drosophila melanogaster gene brain tumor negatively regulates cell growth and ribosomal RNA synthesis. Development 129: 399-407.
29. Frost JK. 1986. "The Cell in Health and Disease: An evaluation of cellular morphologic expression of biologic behavior." New York: Karger.
30. Gant TM, Harris CA, Wilson KL. 1999. Roles of LAP2 proteins in nuclear assembly and DNA replication: Truncated LAP2B proteins alter lamina assembly, envelope formation, nuclear size, and DNA replication efficiency in Xenopus laevis extracts. J Cell Biol 144: 1083-1096.
31. Garcia-Schurmann M, Coffey DS. 1997. The concept of evolution in the pathogenesis and treatment of prostate cancer. Br J Urol 79:9-17.
32. Giardina C, Caniglia DM, D'Aprila M, Lettini T, Serio G, Cipriani T, Ricco R, Pesce Delfino V. 1996. Nuclear morphometry in squamous cell carcinoma (SCC) of the tongue. Eur J Cancer. Part B, Oral Oncol 32B:91-96.
33. Goldberg M, Jenkins H, Allen T, Whitfield WG, Hutchison CJ. 1995. Xenopus lamin B3 has a direct role in the assembly of a replication competent nucleus: Evidence from cell-free egg extracts. J Cell Sci 108:3451-3461.
34. Grunwald V, DeGraffenried L, Russel D, Friedrichs WE, Ray RB, Hidalgo M. 2002. Inhibitors of mTOR reverse doxorubicin resistance conferred by PTEN status in prostate cancer cells. Cancer Res 62:6141-6145.
35. Gurley AM, Hidvegi DF, Cajulis RS, Bacus S. 1994. Morphologic and morphometric features of low grade serous tumours of the ovary. Diagn Cytopathol 11:220-225.
36. Heidenberg HB, Sesterhenn IA, Gaddipati JP, Weghorst CM, Buzard GS, Moul JW, Srivastava S. 1995. Alteration of the tumor suppressor gene p53 in a high fraction of hormone refractory prostate cancer. J Urol 154:414-421.
37. Helpap B, Riede C. 1995. Nucleolar and AgNOR-analysis of prostatic intraepithelial neoplasia (PIN), atypical adenomatous hyperplasia (AAH) and prostatic carcinoma. Pathol Res Pract 191:381-390.
38. Helpap BG, Bostwick DG, Montironi R. 1995. The significance of atypical adenomatous hyperplasia and prostatic intraepithelial neoplasia for the development of prostate carcinoma, an update. Virchows Archiv 426:425-434.
39. Holaska JM, Wilson KL, Mansharamani M. 2002. The nuclear envelope, lamins and nuclear assembly. Curr Opin Cell Biol 14:357-364.
40. Hutchison CJ, Bridger JM, Cox LS, Kill IR. 1994. Weaving a pattern from disparate threads: Lamin function in nuclear assembly and DNA replication. J Cell Sci 107: 3259-3269.
41. Jiang Z, Woda BA, Rock KL, Xu Y, Savas L, Khan A, Pihan G, Cai F, Babcook JS, Rathanaswami P, Reed SG, Xu J, Fanger GR. 2001. P504S: A new molecular marker for the detection of prostate carcinoma. Am J Surg Pathol 25: 1397-1404.
42. Jimenez RE, Fischer AH, Petros JA, Amin MB. 2000. Glutathione S-transferase pi gene methylation: The search for a molecular marker of prostatic adenocarcinoma. Adv Anat Pathol 7:382-389.
43. Kallakury BV, Sheehan CE, Rhee SJ, Fisher HA, Kaufman RP Jr, Rifkin MD, Ross JS. 1999. The prognostic significance of proliferation-associated nucleolar protein p120 expression in prostate adenocarcinoma: A comparison with cyclins A and B1, Ki-67, proliferating cell nuclear antigen, and p34cdc2. Cancer 85:1569-1576.
44. Kastendieck H, Altenahr E. 1976. Cyto- and histomorphogenesis of the prostate carcinoma. A comparative light- and electron-microscopic study. Virchows Archiv. A, Pathol Anat Histol 370:207-224.
45. Kim S, Li Q, Dang CV, Lee LA. 2000. Induction of ribosomal genes and hepatocyte hypertrophy by adenovirus-mediated expression of c-Myc in vivo. Proc Nat Acad Sci USA 97:11198-12002.
46. Kosak ST, Skok JA, Medina KL, Riblet R, Le Beau MM, Fisher AG, Singh H. 2002. Subnuclear compartmentalization of immunoglobulin loci during lymphocyte development. Science 296:158-162.
47. Kurata S, Koga K, Sakaguchi B. 1978. Nucleolar size in parallel with ribosomal RNA synthesis at diapause termination in the eggs of Bombyx mori. Chromosoma 68:313-317.
48. Li F, Ambrosini G, Chu EY, Plescia J, Tognin S, Marchisio PC, Altieri DC. 1998. Control of apoptosis and mitotic spindle checkpoint by survivin. Nature 396:580-584.
49. Liebhaber SA, Wolf S, Schlessinger D. 1978. Differences in rRNA metabolism of primary and SV40-transformed human fibroblasts. Cell 13:121-127.
50. Liu Y, Liang S, Tartakoff AM. 1996. Heat shock disassembles the nucleolus and inhibits nuclear protein import and poly(A) + RNA export. EMBO J 15:6750-6757.
51. Liu CQ, Sasaki H, Fahey MT, Sakamoto A, Sato S, Tanaka T. 1999. Prognostic value of nuclear morphometry in patients with TNM stage T1 ovarian clear cell adenocarcinoma. Br J Cancer 79:1736-1741.
52. Magi-Galluzzi C, Montironi R, Cangi MG, Wishnow K, Loda M. 1998a. Mitogen-activated protein kinases and apoptosis in PIN. Virchows Archiv 432:407-413.
53. Magi-Galluzzi C, Murphy M, Cangi MG, Loda M. 1998b. Proliferation, apoptosis, and cell cycle regulation in prostatic carcinogenesis. Anal Quant Cytol Histol 20:343-350.
54. Mansour SJ, Matten WT, Hermann AS, Candia JM, Rong S, Fukasawa K, Vande Woude GF, Ahn NG. 1994. Transformation of mammalian cells by constitutively active MAP kinase kinase. Science 265:966-970.
55. McNeal JE, Bostwick DG. 1986. Intraductal dysplasia: A premalignant lesion of the prostate. Hum Pathol 17: 64-71.
56. Mohler JL, Partin AW, Epstein JI, Becker RL, Mikel UV, Sesterhenn IA, Mostofi FK, Gleason DF, Sharief Y, Coffey DS. 1992. Prediction of prognosis in untreated stage A2 prostatic carcinoma. Cancer 69:511-519.
57. Mohler JL, Figlesthaler WM, Zhang XZ, Partin AW, Maygarden SJ. 1994. Nuclear shape analysis for the assessment of local invasion and metastases in clinically localized prostate carcinoma. Cancer 74:2996-3001.
58. Moir RD, Spann TP, Goldman RD. 1995. The dynamic properties and possible functions of nuclear lamins. Int Rev Cytol 1626:141-182.
59. Moir RD, Spann TP, Herrmann H, Goldman RD. 2000. Disruption of nuclear lamin organization blocks the elongation phase of DNA replication. J Cell Biol 149: 1179-1192.
60. Montironi R, Braccischi A, Matera G, Scarpelli M, Pisani E. 1991. Quantitation of the prostatic intra-epithelial neoplasia. Analysis of the nucleolar size, number, and location. Pathol Res Pract 187:307-314.
61. Montironi R, Mazzucchelli R, Scarpelli M. 2002. Precancerous lesions and conditions of the prostate: From morphological and biological characterization to chemoprevention. Ann NY Acad Sci 963:169-184.
62. Mutter GL, Ince TA, Baak JP, Kust GA, Zhou XP, Eng C. 2001. Molecular identification of latent precancers in histologically normal endometrium. Cancer Res 61: 4311-4314.
63. Myers RB, Grizzle WE. 1996. Biomarker expression in prostatic intraepithelial neoplasia. Eur Urol 30:153-166.
64. Nativ O, Sabo E, Bejar J, Halachmi S, Moskovitz B, Miselevich I. 1996. A comparison between histological grade and nuclear morphometry for predicting the clinical outcome of localized renal cell carcinoma. Br J Urol 78:33-38.
65. Newport JW, Wilson KL, Dunphy WG. 1990. A lamin-independent pathway for nuclear envelope assembly. J Cell Biol 111:2247-2259.
66. Nierras CR, Liebman SW, Warner JR. 1997. Does Saccharomyces need an organized nucleolus? Chromosoma 105: 444-451.
67. Olson MO, Dundr M, Szebeni A. 2000. The nucleolus: An old factory with unexpected capabilities. Trends Cell Biol 10:189-196.
68. Partin AW, Steinberg GD, Pitcock RV, Wu L, Piantadosi S, Coffey DS, Epstein JI. 1992. Use of nuclear morphometry, gleason histologic scoring, clinical stage, and age to predict disease-free survival among patients with prostate cancer. Cancer 70:161-168.
69. Pederson T. 1998. Growth factors in the nucleolus? J Cell Biol 143:279-281.
70. Phillips SM, Barton CM, Lee SJ, Morton DG, Wallace DM, Lemoine NR, Neoptolemos JP. 1994. Loss of the retinoblastoma susceptibility gene (RB1) is a frequent and early event in prostatic tumorigenesis. Br J Cancer 70: 1252-1257.
71. Pihan GA, Purohit A, Wallace J, Malhotra R, Liotta L, Doxsey SJ. 2001. Centrosome defects can account for cellular and genetic changes that characterize prostate cancer progression. Cancer Res 61:2212-2219.
72. Qian J, Jenkins RB, Bostwick DG. 1997. Detection of chromosomal anomalies and c-myc gene amplification in the cribriform pattern of prostatic intraepithelial neoplasia and carcinoma by fluorescence in situ hybridization. Mod Pathol 10:1113-1119.
73. Rosai J, Carcangiu ML, Delellis RA. 1992. "Tumors of the thyroid gland." Washington: Armed Forces Institute of Pathology.
74. Ruggero D, Pandolfi PP. 2003. Does the ribosome translate cancer? Nature reviews. Cancer 3:179-192.
75. Seker H, Odetayo MO, Petrovic D, Naguib RN, Bartoli C, Alasio L, Lakshmi MS, Sherbet GV. 2002. Assessment of nodal involvement and survival analysis in breast cancer patients using image cytometric data: Statistical, neural network, and fuzzy approaches. Anticancer Res 22:433-438.
76. Signoretti S, Montironi R, Manola J, Altimari A, Tam C, Bubley G, Balk S, Thomas G, Kaplan I, Hlatky L, Hahnfeldt P, Kantoff P, Loda M. 2000. Her-2-neu expression and progression toward androgen independence in human prostate cancer. J Natl Cancer Inst 92: 1918-1925.
77. Spann TP, Moir RD, Goldman AE, Stick R, Goldman RD. 1997. Disruption of nuclear lamin organization alters the distribution of replication factors and inhibits DNA synthesis. J Cell Biol 136:1201-1212.
78. Stefanovsky VY, Pelletier G, Hannan R, Gagnon-Kugler T, Rothblum LI, Moss T. 2001. An immediate response of ribosomal transcription to growth factor stimulation in mammals is mediated by ERK phosphorylation of UBF. Mole Cell 8:1063-1073.
79. Sung SY, Chung LW. 2002. Prostate tumor-stroma interaction: Molecular mechanisms and opportunities for therapeutic targeting. Differentiation 70:506-521.
80. Tanaka TU. 2002. Bi-orienting chromosomes on the mitotic spindle. Curr Opin Cell Biol 14:365-371.
81. Vailancourt L, Ttu B, Fradet Y, Dupont A, Gomez J, Cusan L, Suburu ER, Diamond P, Candas B, Labrie F. 1996. Effect of neoadjuvant endocrine therapy (combined androgen blockade) on normal prostate and prostatic carcinoma. A randomized study. Am J Surg Pathol 20:86-93.
82. Vanguri V, Wang X, Wagner S, Patwardhan N, Khan A, Nickerson JA, Fischer AH. 2003. Nuclear envelope irregularity in cancer cells develops dynamically in interphase: A 3-D time lapse study of living cells, manuscript in preparation.
83. Voit R, Grummt I. 2001. Phosphorylation of UBF at serine 388 is required for interaction with RNA polymerase I and activation of rDNA transcription. Proc Nat Acad Sci USA 98:13631-13636.
84. Volarevic S, Stewart MJ, Ledermann B, Zilberman F, Terracciano L, Montini E, Grompe M, Kozma SC, Thomas G. 2000. Proliferation, but not growth, blocked by conditional deletion of 40S ribosomal protein S6. Science 288:2045-2047.
85. Warner JR. 1999. The economics of ribosome biosynthesis in yeast. Trends Biochem Sci 24:437-440.
86. Warner JR, Vilardell J, Sohn JH. 2001. Economics of ribosome biosynthesis. Cold Spring Harb Symp Quant Biol 66:567-574.
87. Wynford-Thomas D. 1996. p53: Guardian of cellular senescence. J Pathol 180:118-121.
88. Yang L, Guan T, Gerace L. 1997. Lamin-binding fragment of LAP2 inhibits increase in nuclear volume during the cell cycle and progression into S phase. J Cell Biol 139: 1077-1087.
89. Yang XJ, Wu CL, Woda BA, Dresser K, Tretiakova M, Fanger GR, Jiang Z. 2002. Expression of alpha-Methylacyl-CoA racemase (P504S) in atypical adenomatous hyperplasia of the prostate. Am J Surg Pathol 26:921-925.
90. Ye Q, Callebaut I, Pezhman A, Courvalin JC, Worman HJ. 1997. Domain-specific interactions of human HP1-type chromodomain proteins and inner nuclear membrane protein LBR. J Biol Chem 272:14983-14989.
91. Zhang Y, Yu Z, Fu X, Liang C. 2002. Noc3p, a bHLH protein, plays an integral role in the initiation of DNA replication in budding yeast. Cell 109:849-860.